Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (5)
  • 2024 (11)
  • 2023 (23)
  • 2022 (24)
  • 2021 (57)
  • 2020 (12)
  • 2019 (2)
  • 2018 (1)

Subject

  • Prescription Drugs (65)
  • Drug Trafficking (50)
  • Diversion Division (47)
  • Pharmaceuticals/Pharmacists/Physicians (47)
  • Synthetic drugs (37)
  • Seizures (Drugs/Property) (30)
  • Task Forces/Task Force Officers (27)
  • Major Law Enforcement Operation (17)
  • Outreach/Drug Prevention (17)
  • Overdose (16)
  • Arrests/Convictions - Major (13)
  • OCDETF/Task Force (13)
  • Fake Pills (12)
  • Guilty Plea (9)
  • Guns/Weapons (7)
  • One Pill Can Kill (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • Press Conferences (6)
  • Fentanyl Awareness (5)
  • Take Back Day (4)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Dark Web- Internet Trafficking (2)
  • Gangs (2)
  • Asset Forfeiture (1)
  • HIDTA (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Narcoterrorism (1)

Drug Name

  • Fentanyl (2552)
  • Methamphetamine (2107)
  • Cocaine (1906)
  • Heroin (1176)
  • Marijuana (Cannabis) (339)
  • Oxycodone (279)
  • Synthetic Opioids (150)
  • Ecstasy/MDMA (51)
  • Hydromorphone (40)
  • Benzodiazepines (25)
  • Morphine (21)
  • Steroids (18)
  • Ketamine (15)
  • Marijuana Concentrates (14)
  • Methadone (13)
  • Xylazine (12)
  • K2/Spice (11)
  • LSD (11)
  • Psilocybin (5)
  • Synthetic Bath Salts or Designer Cathinones (5)
  • GHB (2)
  • Barbiturates (1)
  • Peyote & Mescaline (1)
  • Opioids (120)
  • Amphetamines (19)

Field Division

  • Washington, DC (55)
  • Miami (13)
  • Seattle (11)
  • New England (8)
  • Atlanta (7)
  • Dallas (6)
  • San Francisco (6)
  • Houston (5)
  • New York (5)
  • Sede (5)
  • St. Louis (5)
  • Chicago (4)
  • New Jersey (2)
  • Detroit (1)
  • Phoenix (1)
  • Rocky Mountain (1)
  • San Diego (1)
Clear All Results
136 Results - Showing 111 to 120
PRESS RELEASE

DEA Washington Division Releases 2020 National Drug Threat Assessment for D.C., Maryland, and Virginia Communities

Washington, D.C. – Today, DEA Acting Administrator D. Christopher Evans, and Special Agent in Charge of the DEA Washington Division, Jarod Forget, announce the release of the 2020 National Drug Threat Assessment – DEA’s annual publication outlining the threats posed to the U.S. by domestic and international drug trafficking and...
PRESS RELEASE

Owner of Tennessee Drug Screening Lab Sentenced to 36 months on Federal Health Care Fraud Charge

ABINGDON, Va. – Michael Dube, who formerly owned and operated American Toxicology Labs, was sentenced was today in U.S. District Court in Abingdon, Virginia to 36 months in federal prison. Jarod Forget, Special Agent in Charge of the DEA Washington Division, Acting United States Attorney Daniel P. Bubar, and Virginia...
PRESS RELEASE

DEA Rolls Out Operation Engage

MIAMI - Today, the United States Drug Enforcement Administration launched a new comprehensive law enforcement and prevention initiative aimed at reducing drug use, abuse, and overdose deaths. “Operation Engage” allows participating field divisions to focus on the biggest drug threat and resulting violence in their respective geographic areas. The initiative...
PRESS RELEASE

DEA Rolls Out Operation Engage

DETROIT – Today the United States Drug Enforcement Administration launched a new comprehensive law enforcement and prevention initiative aimed at reducing drug use, abuse, and overdose deaths. “Operation Engage” allows participating field divisions to focus on the biggest drug threat and resulting violence in their respective geographic areas. The initiative...
PRESS RELEASE

Dark Web Trafficker Pleads Guilty to Distributing Opioids

ALEXANDRIA, Va., – A Florida man pleaded guilty today to unlawfully distributing thousands of prescription opioid pills in exchange for over half a million dollars through the “dark web.” According to court documents, between 2012 and 2020, Daren James Reid, 35, of Fort Lauderdale, used the dark web to distribute...
PRESS RELEASE

Over $1.1M in Civil Settlements Reaffirm DOJ’s Commitment to Preventing Opioid Abuse

S AN ANTONIO - The United States Attorney’s Office has collected $792,000 in civil penalties as two more civil Controlled Substances Act (CSA) investigations have settled, announced Drug Enforcement Administration (DEA) Special Agent in Charge Steven S. Whipple, Houston Division and U.S. Attorney Gregg N. Sofer. These civil settlements, coupled...
PRESS RELEASE

Judge sentences ‘Doctors on the Go’ owner to 9 years in prison for fraud and receiving kickbacks

ST. LOUIS – U.S. District Judge Henry E. Autrey sentenced Denis Mikhlin to 108 months in prison today. The judge also ordered Mikhlin to pay restitution. The 41-year-old St. Louis County, Missouri, resident pleaded guilty in August to four felony counts of conspiracy, obtaining oxycodone and other opioid drugs by...
PRESS RELEASE

Former Roanoke pharmacist sentenced for tampering with powerful narcotics

ROANOKE, Va. – Bryan Wade Lewis, a former pharmacist at Home Choice Partners in Roanoke, was sentenced yesterday in U.S. District Court for tampering with a consumer product, hydromorphone, that affected interstate commerce. Jarod Forget, Special Agent in Charge of the DEA's Washington Division and Acting United States Attorney Daniel...
PRESS RELEASE

DEA honors federal prosecutors for exemplary work in drug-related cases

SAN DIEGO – The Drug Enforcement Administration San Diego Field Division presented awards to several federal prosecutors for their exemplary service and dedication to DEA’s mission in San Diego and the surrounding counties. “It was an honor and a privilege to recognize these Assistant U.S. Attorneys along with U.S. Attorney...
PRESS RELEASE

Uxbridge doctor sentenced to seven years in prison for conspiring to distribute over 3.5 kilograms of amphetamines

BOSTON – An Uxbridge doctor was sentenced on Wednesday, Jan. 13, 2020 in connection with her role in a scheme to prescribe Adderall to individuals without a legitimate medical purpose. Leslie Caraceni M.D., 58, was sentenced by U.S. District Court Judge Timothy S. Hillman to seven years in prison and...

Paginación

  • Primera página «
  • Anterior
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Current page 12
  • Page 13
  • Page 14
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster